clw 3 Flashcards
HTN, HLD, DM, CKD
how to calculate BMI
weight / height^2
EF of HFrEF
≤40%
what to monitor when on statins
Creatinine kinase, statin associated muscle symptoms
when to start fibrates
when TG >5.8
if CK >4xULN, can start statin?
no
if lft more than 3xULN, stop statin?
yes
high risk for future ASCVD events
ACS (within 12m)
MI /stroke
FH
DM
CKD
target LDL for ASCVD, DM more than 10 years or DM with complications (neuropathy, retinopathy, microalbuminuria), familial history
1.8
DM with no complications or less than 10 years
2.6
doubling dose of statin gives reduction of how much
6-7% of LDL
main benefit of statin
reduce risk of mortality, especially for those with underlying ascvd
statin induced AE
dark urine, lethargy, anorexia, stomach pain, light coloured stools, jaundice
monitoring statin: labs?
lipids: 8+-4 weeks when adjusting, else annually
ALT: 8+-4 weeks, routine repeat not recc
CK: not necessary unless got myalgia
hba1c: high dose statin only
sglt2i AE
diabetic ketoacidosis, lightheadedness, fournier gangrene (practise good personal hygiene), UTI, increased urination
GOT of anemia
correct blood loss
remove drug causes
correct iron/folate/b12 deficiency
MOA of ESAs in CKD
Stimulate differentiation of erythroid progenitor stem cells and
induce release of reticulocytes from bone marrow